EX-23.2 7 v027559_ex23-2.htm Unassociated Document
Exhibit 23.2

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Securities and Exchange Commission
Washington, DC

 
We consent to the use in this Registration Statement of ZIOPHARM Oncology, Inc. (formerly EasyWeb, Inc.) on Form SB-2, of our report dated February 19, 2005, appearing in the Prospectus.

We also consent to the reference to us under the heading "Experts" in such Prospectus.

   
/s/  Cordovano and Honeck LLP  

 
Cordovano and Honeck LLP
Denver, Colorado
November 10, 2005